scholarly journals 228: MILLER-FISHER SYNDROME AND COVID VACCINATION

2021 ◽  
Vol 50 (1) ◽  
pp. 99-99
Author(s):  
Navneet Kaur ◽  
Meagan Mayo ◽  
Michael Torres
1993 ◽  
Vol 56 (2) ◽  
pp. 201-203 ◽  
Author(s):  
R K Petty ◽  
R Duncan ◽  
G A Jamal ◽  
D Hadley ◽  
P G Kennedy

2010 ◽  
Vol 121 (4) ◽  
pp. e17
Author(s):  
S. Kostic ◽  
Z. Stevic ◽  
R. Sujic ◽  
V. Cvijanovic ◽  
J. Malovic ◽  
...  

2013 ◽  
Vol 18 (2) ◽  
pp. 195-196 ◽  
Author(s):  
Harrison X. Bai ◽  
Zhi-Li Wang ◽  
Li-Min Tan ◽  
Bo Xiao ◽  
Jonathan M. Goldstein ◽  
...  

Author(s):  
A. Peral Quirós ◽  
F. Acebrón ◽  
M. del Carmen Blanco Valero ◽  
F. Labella Álvarez

2021 ◽  
Vol 14 (7) ◽  
pp. e242231
Author(s):  
Catarina Bernardes ◽  
Cristiana Silva ◽  
Gustavo Santo ◽  
Inês Correia

A 71-year-old woman presented to the emergency room with dysphonia, diplopia, dysphagia and generalised weakness since that day. Neurological examination revealed eye adduction limitation, ptosis, hypoactive reflexes and gait ataxia. Blood and cerebrospinal fluid analysis and brain CT were normal. Electromyography revealed a sensory axonal polyneuropathy. She was diagnosed with Miller-Fisher syndrome (MFS) and started on intravenous immunoglobulin. Two days after intravenous immunoglobulin treatment was completed, she developed a sustained hypertensive profile and presented a generalised tonic-clonic seizure. Brain MRI was suggestive of posterior reversible encephalopathy syndrome (PRES) and supportive treatment was implemented with progressive improvement. PRES may be a possible complication of MFS not only due to autonomic and inflammatory dysfunctions, but also as a consequence of its treatment. Patients with MFS should be maintained under close surveillance, especially in the first days and preferably in intermediate care units.


2010 ◽  
Vol 2010 ◽  
pp. 1-4 ◽  
Author(s):  
Theocharis Papanikolaou ◽  
Cath Gray ◽  
Bernard Boothman ◽  
Gerald Naylor ◽  
George Mariatos

Miller-Fisher syndrome (MFS) is a rare condition characterized by the classical triad of ophthalmoplegia, ataxia, and areflexia (Fisher, 1956). It is considered a variant of Guillain-Barré syndrome (GBS) with which it may overlap, or it can occur in more limited forms. We report a case of a thirty-five-year-old male who presented with a six-day history of diplopia, following a recent chest infection. On examination, he was found to have bilateral sixth nerve palsy, bilateral fourth nerve palsy, bilateral areflexical mydriasis, ataxia and total absence of reflexes. After excluding other conditions, a diagnosis of Miller-Fisher syndrome was made. The patient was administered intravenous immunoglobulin and made an uneventful recovery.


Sign in / Sign up

Export Citation Format

Share Document